Clinical trial
Impact of LILRB5 Genotype on Immune Response to Atorvastatin
NCT02984293 is registered in ClinicalTrials.gov with University of Dundee as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of LILRB5 Genotype on Immune Response to Atorvastatin
- Lead sponsor
- University of Dundee
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 17, 2017
- Completion date
- November 3, 2017
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug intolerance